WallStreetZenWallStreetZen

NASDAQ: SONN
Sonnet Biotherapeutics Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sonnet Biotherapeutics Holdings earnings were -$13.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SONN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.5M, up 10.5% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, SONN reported annual earnings of -$7.4M, with -60.5% growth.

SONN earnings history

Current Revenue
$1.0M
Current Earnings
-$13.3M
Current Profit Margin
-1,328.6%

SONN Return on Equity

Current Company
-778%
Current Industry
-60.2%
Current Market
31.5%
SONN's Return on Equity (-778%)... subscribe to Premium to read more.
High Return on Equity Performance

SONN undefined

Current Company
-271.3%
Current Industry
-2.5%
SONN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SONN announces earnings.

SONN undefined

Current Company
-1,982.23%
Current Industry
5.8%
SONN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SONN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SONN-$13.04M-$13.29MN/A-$11.72
JAGX-$37.87M-$39.73MN/A-$152.39
NBY$4.09M$2.66MN/A$0.91
SPRC$1.96M$1.74MN/A-$0.35
VRAX-$6.43M-$6.58MN/A-$2.61
View Top Biotech Stocks

Sonnet Biotherapeutics Holdings Earnings Reports & History FAQ

What were Sonnet Biotherapeutics Holdings's earnings last quarter?

On SONN's earnings call on Invalid Date, Sonnet Biotherapeutics Holdings (NASDAQ: SONN) reported Q1 2025 earnings per share (EPS) of -$0.89, up 241.27% year over year. Total SONN earnings for the quarter were -$3.49 million. In the same quarter last year, Sonnet Biotherapeutics Holdings's earnings per share (EPS) was $0.63.

If you're new to stock investing, here's how to buy Sonnet Biotherapeutics Holdings stock.

Is Sonnet Biotherapeutics Holdings profitable or losing money?

As of the last Sonnet Biotherapeutics Holdings earnings report, Sonnet Biotherapeutics Holdings is currently losing money. Sonnet Biotherapeutics Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$13.29 million, a 57.67% increase year over year.

What was SONN's earnings growth in the past year?

As of Sonnet Biotherapeutics Holdings's earnings date in Invalid Date, Sonnet Biotherapeutics Holdings's earnings has grown year over year. SONN earnings in the past year totalled -$13.29 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.